ArTS Archivio della ricerca di Trieste

MAGLI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 879
AS - Asia 847
EU - Europa 308
SA - Sud America 85
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.134
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 833
SG - Singapore 335
IT - Italia 184
KR - Corea 126
VN - Vietnam 122
BD - Bangladesh 112
BR - Brasile 56
CN - Cina 56
FR - Francia 27
CA - Canada 26
IN - India 26
PL - Polonia 22
GB - Regno Unito 20
HK - Hong Kong 19
AR - Argentina 18
MX - Messico 13
SE - Svezia 12
AT - Austria 6
ES - Italia 6
FI - Finlandia 6
NL - Olanda 6
IQ - Iraq 5
ID - Indonesia 4
JP - Giappone 4
PH - Filippine 4
PK - Pakistan 4
RU - Federazione Russa 4
SA - Arabia Saudita 4
ZA - Sudafrica 4
AZ - Azerbaigian 3
DE - Germania 3
EC - Ecuador 3
IL - Israele 3
JO - Giordania 3
MA - Marocco 3
PY - Paraguay 3
UZ - Uzbekistan 3
AL - Albania 2
BG - Bulgaria 2
CO - Colombia 2
IE - Irlanda 2
KE - Kenya 2
MY - Malesia 2
SV - El Salvador 2
TH - Thailandia 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
CH - Svizzera 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
JM - Giamaica 1
KG - Kirghizistan 1
MD - Moldavia 1
MN - Mongolia 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
QA - Qatar 1
SI - Slovenia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UA - Ucraina 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.134
Salva come PNG Salva come JPEG
Città #
Singapore 241
Ashburn 199
San Jose 190
Seoul 126
Council Bluffs 66
Ho Chi Minh City 38
Trieste 38
Milan 36
New York 33
Beijing 27
Los Angeles 26
Hanoi 21
Hong Kong 19
Santa Clara 19
Chicago 18
Miano 18
Da Nang 14
Fairfield 12
Haiphong 12
Montreal 11
Zgierz 11
Orem 10
Buffalo 9
Lauterbourg 9
Warsaw 9
Atlanta 8
Denver 8
Houston 8
Olive Branch 8
Dallas 7
Mexico City 6
Mumbai 6
São Paulo 6
Brooklyn 5
Chennai 5
Lappeenranta 5
London 5
Naples 5
Poplar 5
Seattle 5
Toronto 5
Chandler 4
Elk Grove Village 4
New Delhi 4
Philadelphia 4
Phoenix 4
Rome 4
Stockholm 4
Tokyo 4
Amman 3
Biên Hòa 3
Boydton 3
Charlotte 3
Jacksonville 3
Johannesburg 3
North Kansas City 3
Palermo 3
Princeton 3
Querétaro 3
Tampa 3
Tashkent 3
Vienna 3
Washington 3
Wilmington 3
Albano Laziale 2
Ann Arbor 2
Baghdad 2
Baku 2
Bari 2
Boardman 2
Boston 2
Brasília 2
Buenos Aires 2
Cambridge 2
Campinas 2
Can Tho 2
Champlin 2
Columbus 2
Curitiba 2
Dhaka 2
Dublin 2
Florence 2
Goiânia 2
Greenville 2
Guangzhou 2
Hillsboro 2
Hải Dương 2
Lahore 2
Manaus 2
Manchester 2
Montoro 2
Moscow 2
Nairobi 2
Orangeburg 2
Pasadena 2
Riyadh 2
Salt Lake City 2
San Donà di Piave 2
San Salvador 2
Scottsdale 2
Totale 1.458
Salva come PNG Salva come JPEG
Nome #
Brentuximab vedotin in combination with extended field radiotherapy as salvage treatment for primary refractory Hodgkin lymphoma 124
A Systematic Review on Intensity Modulated Radiation Therapy for Mediastinal Hodgkin's Lymphoma 70
18F-Choline-PET-CT (PET) in N stage and radiation treatment planning (RTP) of prostate cancer patients (PCap) at High or unfavorable/intermediate risk (HUIR) 63
A multicenter study of the prognosis and treatment of adult brain ependymonal tumors. 57
Radiation Therapy After Radical Prostatectomy: What Has Changed Over Time? 55
The Prognostic Role of Preoperative PSMA PET/CT in cN0M0 pN+ Prostate Cancer: A Multicenter Study 53
How Has Prostate Cancer Radiotherapy Changed in Italy between 2004 and 2011? An Analysis of the National Patterns-Of-Practice (POP) Database by the Uro-Oncology Study Group of the Italian Society of Radiotherapy and Clinical Oncology (AIRO) 53
Acute patient-reported intestinal toxicity in whole pelvis IMRT for prostate cancer: bowel dose-volume effect quantification in a multicentric cohort study 46
COVID-19 safe and fully operational radiotherapy: An AIRO survey depicting the Italian landscape at the dawn of phase 2 45
Predictors of Patient-Reported Incontinence at Adjuvant/Salvage Radiotherapy after Prostatectomy: Impact of Time between Surgery and Radiotherapy 44
Assessment of PTV margins accounting for prostate intrafraction motion in SBRT with online IGRT 39
COVID-19 outbreak and cancer radiotherapy disruption in italy: Survey endorsed by the italian association of radiotherapy and clinical oncology (AIRO) 39
Comparison of self-reported acute urinary incontinence in pts treated with adjuvant or salvage IMRT 37
A pilot study on the Vanderbilt head and neck symptom survey Italian version (VHNSS-IT) to test its feasibility and utility in routine clinical practice 36
Adjuvant PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) or Gemcitabine followed by chemoradiation in pancreatic cancer: a randomized phase II trial 36
Adaptive radiotherapy nel trattamento radioterapico stereotassico ipofrazionato del tumore della prostata: Dose Tracking vs Re-Optimization 36
Upfront metastasis‑directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance 34
Treatment of muscle-invasive bladder cancer in patients without comorbidities and fit for surgery: Trimodality therapy vs radical cystectomy. Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 31
3T-MRI in the radiation treatment planning of localized prostate cancer using intra-prostatic fiducial markers for CT-registration 30
An image-guided SBRT phase II study with a dose of 42 Gy in 7 fractions for the localized prostate cancer 29
Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: analysis of a large group of patients pooled from three institutions 27
Predictors of 2-Year Incidence of Patient-Reported Urinary Incontinence After Post-prostatectomy Radiotherapy: Evidence of Dose and Fractionation Effects 27
Early results of PRO-EPI: PROspective multicenter observational study on elective pelvic nodes irradiation in patients with intermediate/high/very high-risk non-metastatic prostate cancer submitted to radical, adjuvant, or salvage radiotherapy with or without concomitant androgen deprivation therapy 27
The potential role of SPECT/CT in the clinical management of COVID-19 lung cancer patients undergoing radiotherapy 26
CONTROVERSY PERSISTS OVER THE ACTUAL DOSE–VOLUME RELATIONSHIP AND INDEED WHETHER THE PENILE BULB IS JUST A SURROGATE FOR OTHER NEARBY CRITICAL STRUCTURES, ESPECIALLY GIVEN ITS LIMITED ROLE IN DEVELOPMENT AND MAINTENANCE OF ERECTIONS 26
Comparison of self-reported acute urinary incontinence in patients treated with adjuvant or salvage post-prostatectomy intensity modulated-radiotherapy (IMRT) 26
Correlation Between Dose-Volume Constraints and Late Rectum Bleeding in Patients Treated for Prostate Cancer at Dose Between 70 and 76 Gy 25
Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO). 24
Assessment of PTV Margins Accounting for Prostate Intrafraction Motion in SBRT with Online IGRT 23
Hyperfractionated radiotherapy for T2N0 glottic carcinoma: a retrospective analysis at 10 years follow-up in a series of 60 consecutive patients 22
Breast leiomyosarcoma with myxoid aspects 22
Androgen Deprivation and Late Rectal Bleeding After Radiotherapy for Prostate Carcinoma 22
Pelvic bone marrow dose-volume predictors of late lymphopenia following pelvic lymph node radiation therapy for prostate cancer 22
Stereotactic prostate radiotherapy with or without androgen deprivation therapy, study protocol for a phase III, multi-institutional randomized-controlled trial 21
Hypofractionated simultaneous integrated boost (IMRT-SIB) with pelvic nodal irradiation and concurrent androgen deprivation therapy for high-risk prostate cancer: results of a prospective phase II trial. 20
Dose-effect relationship for early late incontinence after IMRT in post-prostatectomy patients 19
Toxicity profile with hypofractionated RT for localized prostate cancer: compared 3D-CRT vs VMAT 19
Erectile dysfunction after prostate three-dimensional conformal radiation therapy: correlation with the dose to the bulb of the penis 18
Toxicity profile and Patient-Reported outcomes following salvage Stereotactic Ablative Radiation Therapy to the prostate Bed: The POPART multicentric prospective study 18
Prostate Cancer Treatment-Related Toxicity: Comparison between 3D-Conformal Radiation Therapy (3D-CRT) and Volumetric Modulated Arc Therapy (VMAT) Techniques 18
Ruolo della TC/PET con 18F-colina nella stadiazione linfonodale e planning radioterapico nei pazienti con carcinoma della prostate a rischio alto ed intermedio sfavorevole 17
IMRT with simultaneous integrated boost and concurrent chemiotherapy for locoregionally advanced oropharynx squamous cell carcinoma: preliminary results 17
Whole-pelvic nodal irradiation with hypofractionated simultaneous integrated boost for high-risk prostate cancer: outcome and late toxicity. 17
Daily Sodium Butyrate Enema for the Prevention of Radiation Proctitis in Prostate Cancer Patients Undergoing Radical Radiation Therapy: Results of a Multicenter Randomized Placebo-Controlled Dose-Finding Phase 2 Study 17
PREDICTORS FOR RECTAL AND INTESTINAL ACUTE TOXICITIES DURING PROSTATE CANCER HIGH-DOSE 3D-CRT: RESULTS OF A PROSPECTIVE MULTICENTER STUDY 16
MRI-guided contouring in SBRT of the prostate for localized disease 16
PATIENT-SPECIFIC QA OF IMRT PLANS BY EMPLOYING AN EPID-BASED DOSE PREDICTION ALGORITHM 16
Toxicity at 1 Year After Stereotactic Body Radiation Therapy in 3 Fractions for Localized Prostate Cancer 16
Assicurazione di qualità nella radioterapia ad intensità modulata 16
Penalized-Survival Nomogram Predicts 5-Year Metastasis-Free Survival After Salvage Radiotherapy for Postprostatectomy Patients: A Multicenter Study 16
Why we should take care of the competing risk bias in survival analysis: A phase II trial on the toxicity profile of radiotherapy for prostate cancer 16
Prospective longitudinal evaluation of quality of life after prostate cancer IMR 15
QUALITY INDICATORS OF INTENSITY MODULATED-IMAGE GUIDED RADIOTHERAPY (IM-IGRT) CONCOMITANT TO CHEMOTHERAPY (CT): A BENCH-MARKING ANALYSIS FOR CLINICAL AND TECHNICAL GOVERNANCE 15
Phase II trial of pelvic nodal irradiation with hypofractionated IMRTSIB for high-risk prostate cancer 15
Quality of life after whole pelvis RT for prostate cancer: results from a prospective study 15
Adjuvant radiation therapy or observation with or without early salvage radiation therapy for men with node positive prostate cancer after surgery and negative pre-operative conventional imaging: A multicenter study 15
Tecnologie integrate nel trattamento oncologico dei tumori Head & Neck Innovazioni della radioterapia di interesse ORL 15
Unscheduled presentations of urological cancer outpatients in an oncology clinic: a single institution retrospective study 15
Worsening of 2-year patient-reported intestinal functionality after radiotherapy for prostate cancer including pelvic node irradiation 15
The influence of calculation parameters on the patient-QA of p-SBRT plans with VMAT 15
In prostate cancer patients (PC), PET-CT 18F-choline (FC) can incidentally discover un related diseases: our experience in 573 cases 14
Management of de Novo Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) and the Role of Radiation Therapy: A Consensus by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 14
Observation With or Without Subsequent Salvage Therapy for Pathologically Node-positive Prostate Cancer With Negative Conventional Imaging: Results From a Large Multicenter Cohort 14
European Association of Urology Biochemical Recurrence Risk Classification as a Decision Tool for Salvage Radiotherapy—A Multicenter Study 14
SBRT for Prostate Cancer in 3 fractions: Acute Toxicity Rates from a Prospective Multicenter Study 14
Pelvic IMRT with hypofractionated SIB to prostate for high-risk prostate cancer: a phase II study 14
Analysis of patients with locally advanced rectal cancer given neoadjuvant radiochemotherapy with or without RT dose intensification: A multicenter retrospective study – ATLANTIS part I 14
Image-guided hypofractionated radiotherapy for localized prostate cancer with 42Gy in 7 fractions: radiobiogy and preliminary clinical results of a phase II study 14
Radioterapia Oncologica 13
SALVAGE ELECTIVE PELVIC NODAL IRRADIATION (ENRT) COMBINED WITH FOCAL NODAL STEREOTACTIC BODY RADIOTHERAPY (SBRT) IN THE NODAL METACHRONOUS OLIGOMETASTATIC CASTRATION-NAIVE PROSTATE CANCER: A TWOINSTITUTION EXPERIENCE 13
Linee guida carcinoma della prostata. AIOM edizione 2019 13
Laryngeal long-term morbility after supreglottic laryngectomy and postoperative radiation therapy 13
Predictors of Rectal Acute Toxicity in High-Dose 3D-CRT for Prostate Cancer. Results From a Prospective Multi-Centric Study Performed by the AIRO National Working Group on Prostate Irradiation 13
DEVELOPMENT OF A SET OF NOMOGRAMS TO PREDICT ACUTE LOWER GASTROINTESTINAL TOXICITY FOR PROSTATE CANCER 3D-CRT 13
The role of SBRT in oligorecurrent and oligoprogressive prostate cancer: a multi-institutional study 13
Retrospective assessment of treatment planning quality in prostate SBRT 12
Predictors of toxicities and oncological outcomes following postoperative ablative radiotherapy (POPART) for biochemical recurrence 12
Dose-effect relationship for 1-year incontinence after post-prostatectomy intensitymodulated radiotherapy (MRT) 12
Radioterapia stereotassica body (42Gy in 7 frazioni settimanali) nei tumori localizzati della prostata: valutazioni radiobiologiche e primi risultati 12
STEREOTACTIC BODY RADIOTHERAPY FOR LOW AND INTERMEDIATE RISK PROSTATE CANCER. TOXICITY RESULTS OF PHASE II STUDY 12
Quality of Life Longitudinal Evaluation in Prostate Cancer Patients from Radiotherapy Start to 5 Years after IMRT-IGRT 12
Il ruolo della radioterapia nel linfoma di Hodgkin: luci e ombre agli arbori del XXI secolo 12
IG-SBRT for localized prostate cancer: clinical results and late toxicity of a phase-II study 12
Patient-reported persistent symptoms after radiotherapy and association with quality of life for prostate cancer survivors 12
IGRT con 3D-CRT ipofrazionata nel carcinoma prostatico a rischio intermedio mediante marcatori fiduciali intraprostatici: risultati di studio di fase II 11
RT for the management of locally advanced rectal cancer: Don't throw the baby with the bath water! 11
FDG-PET/CT for target volume delineation in the intensity-modulated radiotherapy with simultaneous integrated boost (IMRT-SIB) and concurrent chemotherapy (CHT) for locoregionally advanced oropharynx squamous cell carcinoma: preliminary resuls 11
Predictors of acute lymphopenia after radiotherapy for prostate cancer including pelvic node irradiation: results of a real-world prospective multi-centric study 11
Stereobody radiotherapy (42Gy/7fx) for localized prostate cancer: radiobiology and first results 11
Le metastasi cerebrali: aspetti diagnostici e terapeutici 10
PRACTICE PATTERNS FOR PROSTATE CANCER IN NINE CENTRAL AND NORTHERN ITALY RADIATION ONCOLOGY CENTERS: A SURVEY INCLUDING 1759 PATIENTS TREATED DURING TWO DECADES (1980–1998) 10
La radioterapia nel trattamento degli adenomi ipofisari: risultati e prospettive 10
Accurate prediction of long-term risk of biochemical failure after salvage radiotherapy including the impact of pelvic node irradiation 10
Stereotactic Radiotherapy for Localised Prostate Cancer: Time to Clarify the Possible Impact of Concurrent Androgen Deprivation Therapy 10
Il ruolo della radioterapia nel trattamento integrato del carcinoma del retto e giunzione retto-sigma 10
Phase-II study of sbrt for localized prostate cancer: outcome and late toxicity 9
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 9
Stereotactic Radiotherapy and Androgen Deprivation Therapy for Localized Prostate Cancer: A Retrospective Mono-institutional Experience 9
Irradiazione pelvica con tecnica IMRT-SIB nei pazienti con tumour della prostate ad alto rischio: risultati di studio di fase II 9
PET/CT FOR TREATING LOCOREGIONALLY ADVANCED OROPHARYNX SQUAMOUS CELL CARCINOMA WITH IMRT-SIB AND CHT 9
Totale 2.195
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.670
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.670
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 0 0 2
2021/202211 0 1 0 2 0 0 1 0 1 2 0 4
2022/202316 2 2 2 0 2 3 0 1 2 0 2 0
2023/20248 0 0 1 0 1 1 2 2 0 0 0 1
2024/202514 0 0 0 1 2 2 1 1 1 2 1 3
2025/20262.262 4 0 1 266 173 226 90 75 377 541 336 173
Totale 2.337